日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combined pyrotinib and fulvestrant for hormone receptor-positive and HER2-positive metastatic breast cancer: A multicenter, single-arm, phase II trial

吡咯替尼联合氟维司群治疗激素受体阳性和HER2阳性转移性乳腺癌:一项多中心、单臂II期试验

Zhao, Jianli; Yu, Yunfang; Ren, Wei; Ding, Linxiaoxiao; Chen, Yongjian; Yuan, Peng; Yue, Jian; Yang, Yaping; Zou, Guorong; Chen, Tao; Chai, Jie; Zhang, Li; Wu, Wenjing; Zeng, Yinduo; Gui, Xiujuan; Cai, Yangyang; Luo, Simin; Yuan, Zhongyu; Zhang, Kang; Yao, Herui; Wang, Ying

Excellent efficacy of trastuzumab deruxtecan in a patient with HER2-positive advanced breast cancer complicated by pulmonary lymphangitic carcinomatosis: a case report and literature review

曲妥珠单抗德鲁替康治疗HER2阳性晚期乳腺癌合并肺淋巴管癌病患者疗效显著:病例报告及文献复习

Luo, Simin; Chai, Jie; Ding, Linxiaoxiao; Tang, Song

Prognostic Value of Distant Micrometastasis in Breast Cancer: A Population-Based Propensity Score-Matched Study

远处微转移在乳腺癌预后中的价值:一项基于人群倾向评分匹配的研究

Luo, Simin; Wang, Ying; Zhao, Jianli; Ding, Linxiaoxiao; Wu, Wenjing; Zeng, Yinduo; Tang, Song

Causality between telomere length and breast diseases: a two-sample bidirectional Mendelian randomization study

端粒长度与乳腺疾病的因果关系:一项双样本双向孟德尔随机化研究

Luo, Simin; Chai, Jie; Cai, Yangyang; Ding, Linxiaoxiao; Tang, Song

Ductal lavage followed by observation versus oral corticosteroids in idiopathic granulomatous mastitis: A randomized trial

导管冲洗后观察与口服皮质类固醇治疗特发性肉芽肿性乳腺炎的随机试验

Chen, Xiaolin; Huang, Heng; Huang, Hui; Yong, Juanjuan; Zhu, Liling; Chen, Qianru; Tan, Luyuan; Zeng, Yinduo; Yang, Yaping; Zhao, Jianli; Rao, Nanyan; Ding, Linxiaoxiao; Wu, Wenjing; Li, Yudong; Gui, Xiujuan; Ye, Liming; Xu, Yanlian; Jiang, Yumei; Su, Linhong; Xiao, Qiaozhen; Cai, Xueying; Hu, Tingting; Tan, Cui; Liu, Qiongmei; Liu, Shuyi; Zhao, Jinghua; Wang, Ying; Yu, Fengyan; Zhang, Jian; Li, Shunrong; Chen, Kai

Sequential neoadjuvant chemotherapy using pegylated liposomal doxorubicin and cyclophosphamide followed by taxanes with complete trastuzumab and pertuzumab treatment for HER2-positive breast cancer: A phase II single-arm study

HER2阳性乳腺癌患者接受序贯新辅助化疗(聚乙二醇化脂质体阿霉素和环磷酰胺)后序贯紫杉烷类药物联合曲妥珠单抗和帕妥珠单抗治疗:一项II期单臂研究

Yang, Yaping; Jin, Liang; Li, Yudong; Rao, Nanyan; Gong, Chang; Li, Shunrong; Wu, Jiannan; Zhao, Jinghua; Ding, Linxiaoxiao; Gan, Fengxia; Zhang, Jun; Feng, Ruifa; Liu, Zhenzhen; Liu, Qiang

Somatic mutations in four novel genes contribute to homologous recombination deficiency in breast cancer: a real-world clinical tumor sequencing study

四种新基因的体细胞突变导致乳腺癌同源重组缺陷:一项真实世界的临床肿瘤测序研究

Yongsheng Huang #, Yuntan Qiu #, Linxiaoxiao Ding #, Shuwei Ren #, Yuanling Jiang, Jiahuan Luo, Jinghua Huang, Xinke Yin, Sha Fu, Jianli Zhao, Kaishun Hu, Jianwei Liao

Development and validation of a nomogram in survival prediction among advanced breast cancer patients

晚期乳腺癌患者生存预测列线图的建立与验证

Zhao, Jianli; Yang, Yaping; Pang, Danmei; Yu, Yunfang; Lin, Xiao; Chen, Kai; Ye, Guolin; Tang, Jun; Hu, Qian; Chai, Jie; Bi, Zhuofei; Ding, Linxiaoxiao; Wu, Wenjing; Zeng, Yinduo; Gui, Xiujuan; Liu, Donggeng; Yao, Herui; Wang, Ying

NKILA represses nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB pathway inhibition

NKILA 通过抑制 NF-κB 通路抑制鼻咽癌的致癌作用和转移

Wei Zhang, Qiannan Guo, Guoying Liu, Fang Zheng, Jianing Chen, Di Huang, Linxiaoxiao Ding, Xing Yang, Erwei Song, Yanqun Xiang, Herui Yao